dr. kimberly blackwell discusses the t-dm1 emilia trial
Published 12 years ago • 1.2K plays • Length 1:50Download video MP4
Download video MP3
Similar videos
-
1:04
dr. kimberly blackwell discusses the t-dm1 emilia trial coprimary endpoints
-
4:52
emilia trial: t-dm1 in metastatic breast cancer
-
1:21
dr. louis weiner discusses the t-dm1 emilia trial for her2-positive breast cancer
-
9:58
kimberly l. blackwell: primary results from emilia
-
1:38
dr. debu tripathy discusses the updated emilia trial results for t-dm1
-
0:46
dr. kimberly l. blackwell on a promising her2 breast cancer treatment
-
11:21
dr. kimberly blackwell: treatment innovations in targeting the her-2 receptor - part 1
-
1:39
dr. blackwell on treatment landscape of her2 breast cancer
-
19:46
metastatic breast cancer: what you need to know
-
33:35
which metastatic breast cancer treatment is right for you? what you need to know
-
1:20:55
treatment of metastatic breast cancer
-
1:00
dr. blackwell discusses margetuximab for her2 breast cancer
-
2:05
duke cancer institute's dr. kimberly blackwell discusses new treatment for breast cancer
-
1:38
t-dm1 plus pertuzumab in the marianne trial
-
1:04
dr. perez on t-dm1 and the marianne trial
-
0:52
dr. blackwell on emerging therapies in tnbc
-
1:15
dr. blackwell on the impact of the cleopatra and marianne studies in her2 breast cancer
-
2:36
dr. blackwell discusses tucatinib in her2 breast cancer
-
2:02
kimberly blackwell, md: expectations of therapy
-
3:22
kimberly blackwell, md: expectations of therapy in breast cancer
-
1:43
dr. blackwell discusses the her2climb study in her2 breast cancer
-
3:03
kimberly blackwell, md: clinical trial data supporting these choices